All recurrent genital herpes articles
-
NewsResearcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpes
University of California, Irvine immunologist Lbachir BenMohamed has been awarded a $3.93 million National Institutes of Health grant to develop and test a novel therapeutic vaccine designed to prevent recurrent genital herpes.